Source: https://www.paulhastings.com/professionals/details/naveenmodi
Timestamp: 2019-04-19 12:54:42+00:00

Document:
Mr. Modi’s practice includes all aspects of patent-related work, including litigation (U.S. district court and U.S. International Trade Commission), post-grant proceedings, interferences, client counseling, appeals, and opinions. Having been involved in well over 400 post-grant proceedings, including inter partes review (IPR), post-grant review (PGR), covered business method (CBM) review, and ex parte and inter partes reexamination proceedings, Mr. Modi is one of the foremost experts in challenging and defending patents before the United States Patent and Trademark Office under the America Invents Act, including its Patent Trial and Appeal Board (PTAB). Mr. Modi has been involved in the most number of PTAB proceedings than any other practitioner in the United States.
Mr. Modi has been nationally recognized for his expertise in post-grant proceedings. Chambers USA recognized him as an expert in this area, noting that he “earns effusive praise from clients, who describe him as ‘a brilliant litigator.’ One source reports: ‘Naveen understands all of the rules and subtleties of IPR proceedings better than anyone I've ever worked with.’” Managing Intellectual Property also recognized him as Outstanding IP Litigator of the Year for PTAB. It also named him as an IP Star, noting that he “has developed a significant reputation for his post-grant proceeding practice” and that “[a] top competitor said: ‘Naveen is probably the country’s leader in patent trials before the Patent Trial and Appeal Board. He is simply the most brilliant attorney I’ve worked with.’” One peer added he “would trust him with the crown jewels.” Mr. Modi has been recommended by Legal 500 “for his notable experience in post-grant proceedings.” Law360 has recognized him as a “Legal Lion” and “IP MVP” for his work defending Acorda in the highly publicized IPRs filed by a hedge fund run by Kyle Bass. Financial Times has also “highly commended” his work in connection with these IPRs. Mr. Modi was also recognized as a “Legal Lion” for his work for Boehringer Ingelheim on IPRs where, as Law360 noted, the PTAB “invalidated ‘a key patent’ for AbbVie Inc.’s top selling drug . . . Humira.” In addition Mr. Modi was recognized by Law360 as a “legal lion” for his work for Google. His team successfully obtained four wins at the PTAB, convincing the board to invalidate three of Blackberry Ltd.’s patents related to smartphone technology. Mr. Modi and his team also secured a win for Google and LG Electronics at the Federal Circuit. LMG Life Sciences recognized Mr. Modi as an IP Star in addition to being awarded the Post Grant Proceedings Attorney of the Year at the LMG Life Sciences Awards.
Mr. Modi devotes a portion of his time to serving the bar and pro bono matters. He currently serves as the President for the PTAB Bar Association. He successfully represented an individual in his request for asylum before the Immigration Court.
Liqwd, Inc. v. L’Oreal USA, Inc., (D. Del.). Representing L’Oreal USA in patent litigation involving hair products.
Zimmer Biomet Holdings, Inc. v. Four Mile Bay, LLC (N.D. Ind.). Representing Zimmer Biomet in patent litigation and IPRs involving medical devices.
University of Western Australia v. Academisch Ziekenhuis Leiden. Representing BioMarin in Federal Circuit Appeals.
Elm 3DS Innovations, LLC v. Samsung Electronics Co., LTD. (D. Del.). Representing Samsung in a patent litigation and IPRs involving semiconductor technology.
Advanced Marketing Systems LLC v. Walgreen Co. (E.D. Tex.). Representing Walgreen in a patent litigation and CBMs involving software.
Rothschild Mobile Imaging Innovations, LLC v. Mitek Systems, Inc. (D. Del.). Representation of Mitek in patent litigation and IPRs involving software.
Representation of various companies, including Acorda, AT&T, Boehringer Ingelheim, Corelogic, Covidien, eBay, Fitbit, Google, Helsinn, Insys, Mitek, Opinion Lab, PayPal, Samsung, and Zimmer, in post-grant proceedings, including inter partes review and post-grant review.
Back Bay Medical Inc. v. Covidien Holding Inc. (C.D. Cal.). Represented Covidien in a patent litigation involving medical devices.
Parallel Networks, LLC v. SAP America, Inc. (D. Del.), Aloft Media, LLC v. SAP AG (E.D. Tex.), and elcommerce.com, Inc. v. SAP AG (E.D. Pa.). Represented SAP in a patent litigation involving software.
TPK Touch Solutions, Inc. v. Wintek Electro-Optics Corporation (N.D. Cal.). Represented Wintek in a patent litigation and IPRs involving touch panels.
In re Certain Semiconductor Chips and Products Containing the Same, 337-TA-753 (ITC) and In re Certain Semiconductor Chips Having Synchronous Dynamic Random Access Memory Controllers, 337-TA-661 (ITC). Represented Rambus in a patent infringement case involving semiconductor devices.
Medtronic, Inc. v. Guidant Corp. (D. Del.) and Guidant Corp. v. St. Jude Medical, Inc. (D. Del.). Represented Guidant in patent infringement cases involving medical devices.
Supinski v. Cohen (B.P.A.I.). Represented Zimmer in a patent interference involving medical devices.
Rambus Inc. v. International Business Machines Corp. (N.D. Cal.). Represented Rambus in a patent interference case involving semiconductor devices.
Lalonde v. Li (B.P.A.I.) and Prutchi v. Lofgren (B.P.A.I.). Represented Boston Scientific in patent interferences involving medical and semiconductor devices.
How can technology companies navigate PTAB's post-grant patent proceedings?
Paul Hastings was was recognized by Managing IP at their Americas Awards, which honored individuals and companies behind the most innovative and challenging IP work of the past year, as well as those driving the international IP market. The firm was recognized as Life Sciences IP Litigation Firm of the Year in the United States.
Naveen Modi, global vice chair of the Firm’s Intellectual Property Practice, was named Outstanding Litigator of the Year Award: PTAB, an award he also received in 2016. Managing IP noted several of Modi’s wins at the PTAB, including the invalidation of a hip implant patent on behalf of Zimmer Biomet.
Paul Hastings was recognized in the 2018 edition of LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation. LMG Life Sciences selected seven individual lawyers as "Life Sciences Stars," including Eric Dittmann, Gary Giampetruzzi, Naveen Modi, Joseph O’Malley, Chad Peterman, Preston Ratliff, and Bruce Wexler. Earlier this year, LMG Life Sciences honored the firm with the LMG Life Sciences award for Hatch-Waxman Litigation Firm of the Year – Branded.
LMG Life Sciences announced that the firm’s Intellectual Property practice was honored at the LMG Life Sciences Awards as the Hatch-Waxman Litigation Firm of the Year (Branded). The publication cited the firm for wins on behalf of Sunovion Pharmaceuticals, which locked in compound patent protection for Latuda®, the company’s billion-dollar-plus-per-year schizophrenia and bipolar drug, after a judgment of infringement that was affirmed by the Federal Circuit; and for Orexigen Therapeutics after a trial victory where the judge found all three patents-in-suit to be valid and infringed. The firm was also noted for obtaining an unprecedented six walk-away consent judgments in a major pharmaceutical litigation.
Paul Hastings was recognized in LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation. LMG Life Sciences selected seven individual lawyers as "Life Sciences Stars," including Joseph O’Malley, Bruce Wexler, Gerald Flattmann, Naveen Modi, Chad Peterman, Eric Dittmann, and Gary Giampetruzzi.
Patexia acknowledged Naveen Modi as the most active attorney representing petitioners and patent owners in inter partes review (IPR) proceedings at the Patent Trial and Appeal Board (PTAB). Patexia noted that Naveen's workload of 240 cases is the most among the 5,000 attorneys who have worked on IPRs since 2012.
Paul Hastings was recognized in LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation. LMG Life Sciences selected six individual lawyers as "Life Sciences Stars," including Joseph O’Malley, Bruce Wexler, Gerald Flattmann, Gary Giampetruzzi, Naveen Modi, and Eric Dittmann.
Paul Hastings was recognized with multiple LMG Life Sciences Awards. Bruce Wexler was named “General Patent Litigator of the Year – New York” and Naveen Modi was recognized as Post Grant Proceedings Attorney of the Year. The Life Sciences Patent Litigation practice also won awards for two Hatch-Waxman Impact Cases of the Year, including Helsinn Healthcare SA v. Teva Pharmaceuticals USA, a win resolving a long-running patent dispute over Aloxi®, a drug used to treat chemotherapy-induced nausea and vomiting. The Paul Hastings team representing Helsinn was led by Joseph O’Malley. The firm was also honored for its work on behalf of Eli Lily in Sanofi-Aventis US v. Eli Lilly & Co., where Bruce Wexler led the team representing Eli Lily in litigation regarding the marketing of Basaglar®, its insulin glargine drug product. The case was settled in late 2015, with the press reporting Eli Lilly’s ability to launch the drug.
The Firm was shortlisted in four categories for the LMG Life Sciences Awards. Joseph O’Malley was nominated in the Hatch-Waxman Litigator of the Year – Branded category, Bruce Wexler was nominated in the General Patent Litigator of the Year - New Yorkcategory, Naveen Modi was nominated in the Post Grant Proceedings Attorney of the Year category, and the Firm was nominated in the “Hatch-Waxman Litigation Firm of the Year – Branded” category.
Naveen Modi was named Outstanding IP Litigator of the Year – PTAB at Managing IP's 2016 North America Awards. Additionally, Paul Hastings was shortlisted in the US Life Sciences IP Litigation Firm of the Year, Patent Contentious Northeast Firm of the Year, and PTAB Firm of the Year categories.
Gerald Flattmann and Naveen Modi were named as MVP award winners by Law360 in the Intellectual Property category. Law360 reviewed more than 850 submissions, selecting attorneys with “successes in high-stakes litigation, record-breaking deals and complex global matters” as this year’s MVP award winners.

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.